Solana Co

Solana Company operates primarily as a digital asset treasury focused on acquiring, holding, and managing Solana tokens, while also engaging in network staking and yield-generation activities across the blockchain ecosystem. To a smaller extent, the enterprise functions as a neurotechnology and medical device developer. Its flagship healthcare product is the Portable Neuromodulation Stimulator (PoNS), a non-implantable medical device combining a controller and mouthpiece with supervised exercise therapy to treat neurological balance and gait deficits. The organization's target customers comprise public market investors seeking cryptocurrency exposure, institutional blockchain partners such as market makers and exchanges, as well as adult physical therapy and rehabilitation patients.

The business maintains regulatory authorizations and commercial operations across the United States, Canada, and Australia. It employs 21 full-time workers, including 18 located in the United States, two in Canada, and one in Hong Kong. In addition, its digital asset reserves are stored with two custodians in the United States. Corporate headquarters are located in Newtown, Pennsylvania.

Summary of the business section of Solana's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 21 full-time employees, of which 18 are located in the United States, two are located in Canada and one is located in Hong Kong.”